Alphatec Holdings, Inc. (ATEC) vs Ocular Therapeutix, Inc. (OCUL)

A side-by-side comparison of Alphatec Holdings, Inc. and Ocular Therapeutix, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ATEC vs OCUL

growth of $100 · dividends reinvested · last 10y
ATEC +46.2% (+3.9%/yr)OCUL +5.8% (+0.6%/yr)ATEC compounded faster over this window
0100200300Start $10020182020202220242026$146$106
ATEC OCUL

ATEC vs OCUL: by the numbers

  • •ATEC is the larger company ($1.62B vs $1.61B market cap).
  • •Both run net losses; ATEC's is the smaller (-13.50% vs -579.10% net margin).
  • •ATEC grew revenue faster over the past five years (33.61% vs 10.03% CAGR).

Metrics side by side

Valuation

MetricATECOCUL
Forward P/E32.27N/A
P/S ratio1.9930.87
P/B ratioN/A3.09
EV / EBITDA56.65N/A
FCF yield0.26%N/A

Profitability

MetricATECOCUL
Gross margin66.15%87.11%
Operating margin-5.55%-521.04%
Net margin-13.50%-579.10%
ROEN/A-57.97%
ROIC-7.32%-50.20%

Growth (annualized)

MetricATECOCUL
Revenue CAGR (5Y)33.61%10.03%
Total return CAGR (5Y)-2.26%-5.73%

Frequently asked

Which has grown faster, ATEC or OCUL?
Over the past five years, ATEC grew revenue faster — ATEC at a 33.61% CAGR versus OCUL at 10.03%.
How have ATEC and OCUL total returns compared?
Over the past 10 years, ATEC delivered 3.88% and OCUL delivered 0.44% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.